CJ Surpasses Annual Production of IV Solutions Over 30 Million Units

Published: 2004-12-28 06:57:00

Updated: 2004-12-28 06:57:00

CJ Pharmaceutical Division achieved its annual production of intravenous (IV) fluid sets and solutions surpassing 30 million units per year, driving the total IV solution revenue of 40 billion won for the current year.

Prior the early 1990’s, the domestic pharmaceutical manufacturers did not s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK